Turning off cancer’s growth signals
Biological engineers’ new approach to shutting down cell division could lead to new cancer drugs.
Search Stories
The past, present and future of cancer
Researchers gather to discuss the state of their field and the potential for new treatments.
Anne Mayes, former materials science professor, dies at 46
'Fiercely dedicated to MIT students,' she established fellowship prior to leaving the Institute.
Delivering a potent cancer drug with nanoparticles can lessen side effects
The new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.
Using the body’s own defenses to combat cancer
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.
MIT Medical promotes employee mammograms
No referral or copay for female employees between 40 and 70 who are enrolled in any MIT-sponsored health-insurance plan.
Getting bacteria to do a plant’s job
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
Super-sizing a cancer drug minimizes side effects
Researchers design a new version of cisplatin that spares the kidneys, letting doctors use higher doses.
Taking aim at aggressive cancer cells
Researchers use novel stem-cell method to discover chemical with potency against breast tumors in mice